Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

748186

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Piperacillin/tazobactam: Shortages
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will estimate the potential cost to the NHS of longer (a) treatment times and (b) hospital stays as a result of prescribing less powerful antibiotics as a result of the international shortage of the antibiotic piperacillin-tazobactam.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	2903
answer	answer is ministerial correction date of answer 10/07/2017 answer text <p>No such estimate has been made. In response to the shortage of piperacillin-tazobactam, the Department has been working with national antimicrobial leads through Public Health England and the Department’s Expert Advisory Group on Antimicrobial Prescribing Resistance and Healthcare Associated Infections who published guidance on appropriate alternative treatment options to ensure that any impact on patient care has been minimised. This guidance provided recommendations on the different broad spectrum antibiotics, or a combination of narrower spectrum antibiotics that can be used to treat the range of infections for which piperacillin-tazobactam is licensed.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/07/2017 14:38:55 answering member 4067 label Biography information for Steve Brine
tabling member	4342 label Biography information for Liz McInnes

748212

registered interest
date	04/07/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Piperacillin/tazobactam
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he plans to take to ensure future supplies of the Tazocin brand of the antibiotic piperacillin-tazobactam.
tabling member constituency	Heywood and Middleton
tabling member printed	Liz McInnes
uin	2915
answer	answer is ministerial correction date of answer 10/07/2017 answer text <p>The Department is in direct contact with all suppliers of piperacillin-tazobactam about future supplies coming into the United Kingdom, including Pfizer who market the brand Tazocin. Pfizer currently have supplies available and have confirmed that they are able to bring larger volumes of Tazocin to the UK market from October onwards. Several other suppliers of generic piperacillin-tazobactam injection have also confirmed supplies are available and there is no clinical preference between any given manufacturer’s version of the medicine.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/07/2017 15:14:31 answering member 4067 label Biography information for Steve Brine
tabling member	4342 label Biography information for Liz McInnes